SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Chemokines and their Receptors
An SI Board Since February 2001
Posts SubjectMarks Bans
70 18 0
Emcee:  keokalani'nui Type:  Unmoderated
Introduction Compact
Please feel free to post on this interesting topic.
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
70Interpretation #3: The good memory of ever owning a BT left me disoriented. keokalani'nui-12/18/2008
69>>I feel vaguely disoriented<< What ? That it's been two yearsnigel bates-12/18/2008
68Wow, a good memory. I feel vaguely disoriented.keokalani'nui-12/15/2008
67FDA Approves Genzymes Mozobil Monday December 15, 4:59 pm ET Product provides ennigel bates-12/15/2008
66zeta hits one with nejm review Message 22147112keokalani'nui-2/8/2006
65Chemokine Therapeutics receives U.S. Patent for novel cancer drug in clinical demopgcw-6/14/2005
64NBIX CCR7/CCL21 and CXCR4/CXCL12 for cancer Semin Cancer Biol. 2004 Jun;14(3keokalani'nui-7/26/2004
63ChemoCentryx Raises $33 Million in Private Financing Thursday June 17, 8:30 am Enigel bates-6/17/2004
62wow, cool. thanks.scaram(o)uche-4/6/2004
61Click on this and go to the bottom, click on 'chemokine facts and figureskeokalani'nui-4/6/2004
60for me, link didn't work....... "Error Occurred While Processing Requscaram(o)uche-4/6/2004
59I'm not done. Check this out. The chart at the bottom, that is. . normekeokalani'nui-4/6/2004
58>> I think il-18 is also considered a ligand << I not only get valuscaram(o)uche-4/6/2004
57Rick Among the stuff I've archived, I can't find anything more than thekeokalani'nui-4/6/2004
56thanks! ok, I'll squawk at 10-K Wiz. Again.scaram(o)uche-4/6/2004
55I don't know of any. I might have some notes available tomorrow. Serono iskeokalani'nui-4/6/2004
54Do you know of companies, beyond Incyte and MLNM, that are working on CCR2 antagscaram(o)uche-4/5/2004
53<i>(CCRI)</i>ChemoCentryx and Forest Laboratories to Collaborate on nigel bates-3/15/2004
52CCR2 and islet rejection. Differential Role of CCR2 in Islet and Heart Allografkeokalani'nui-1/5/2004
51Role of CXCL9/CXCR3 Chemokine Biology during Pathogenesis of Acute Lung Allografkeokalani'nui-10/20/2003
50You'll recall chemocentryx delivered/collaborated with tlrk's ccr2 targekeokalani'nui-10/13/2003
49ChemoCentryx Awarded $14 Million NIH Grant to Develop Chemokine-Based Immunomodunigel bates-10/13/2003
48Had a look at some of the Berlex patents. A little intimidating, if you're nigel bates-10/8/2003
47[CCR1-Schering-Alzheimer's Imaging Agent] Message 19381283keokalani'nui-10/8/2003
46[CCR2] INCY announces its first internal drug platform is the development of an keokalani'nui-5/6/2003
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News